NCC Medical Group is a globally recognized manufacturer specializing in advanced neurodiagnostic and neuromonitoring technologies. As a nationally recognized SRDI “Little Giant” enterprise, NCC represents one of the leading innovators in the neurophysiology medical device industry. The SRDI designation—Specialized, Refined, Differential, and Innovational—is awarded to companies that demonstrate strong technological capabilities and core patented innovations.
Founded in 1997, NCC has accumulated more than two decades of experience in the development of neurodiagnostic systems and intraoperative neuromonitoring equipment. The company’s primary research and manufacturing center is located in Shanghai, China, a major global hub for high-technology medical device development. From this center, NCC conducts advanced research in neurophysiology monitoring technologies while maintaining strict manufacturing standards.
To ensure international product quality and regulatory compliance, NCC operates a dedicated quality management and compliance center in Singapore. This facility supports global regulatory alignment, product certification, and international distribution management. Through this dual-center structure, NCC ensures that all products meet the requirements of healthcare institutions worldwide.
NCC specializes in multiple areas of neurophysiology technology, including intraoperative neuromonitoring (IONM), electroencephalography (EEG), polysomnography (PSG), electromyography (EMG), and neurophysiology medical consumables. These technologies are widely used in hospitals for neurological diagnostics, surgical monitoring, and advanced patient care.
The company’s operational strategy is built around three key pillars. The first pillar is research and manufacturing, where engineering teams focus on innovation in neurophysiology monitoring technologies and precision device production. The second pillar is global sales and export operations, which support international expansion through partnerships with distributors and healthcare institutions worldwide. The third pillar is clinical service and innovation, which provides professional training, technical support, and continuing education for healthcare providers.
Today, NCC’s clinical solutions are deployed in more than 50 countries and installed in over 5,000 hospitals across China. Hospitals rely on NCC technologies for accurate neurodiagnostic testing and reliable intraoperative monitoring. From major university hospitals to regional surgical centers, NCC systems support medical professionals in delivering safer surgeries and better patient outcomes.
To further support clinical users, NCC has established 31 training and technical support centers across China, providing hands-on education for clinicians and biomedical engineers. Through the NCC Innovation Academy, healthcare professionals receive continuous professional education on neurophysiology technologies such as EEG, EMG, and intraoperative neuromonitoring.
NCC is also actively expanding its global distributor network. By collaborating with international medical device partners, the company aims to make advanced neuromonitoring technologies more accessible to hospitals around the world.
Guided by its mission of “Safeguarding Life and Health,” NCC remains committed to advancing safer surgical procedures, improving diagnostic accuracy, and supporting high-quality patient care through innovative neurophysiology technologies.
Copyright © NCC Medical Co., Ltd. - Privacy policy